4.8 (77) In stock
BioVie's NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson's Disease Patients and May Be Realigning Physiological Processes for Alzheimer's Patients in Data to be Presented at the International Conference
lipid homeostasis
Multimorbid diseases cluster in predictable ways: study, 2021-03-19
BioVie (BIVI): Treating Alzheimer's, Parkinson's, Reversing The Biological Clock
BioVie's NE3107 Demonstrates Potential Improvements in
Noninvasix breathes easier with breakthrough device designation
BioVie Highlights Encouraging NE3107 Data In Parkinson's, Alzheimer's Trials
BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer's Disease
ADS-024 restores movement in mice with PD
dementia BioWorld
BioVie Announces EfficacyData from Phase 3 Trial of NE3107 in Patientswith Mild to Moderate Alzheimer's Disease
Exevir Bio BV
Changes in microbiome impact neurodegeneration in Alzheimer's model
